首页> 美国卫生研究院文献>Clinical and Experimental Immunology >Nuclear phosphotyrosyl-protein with DNA-binding ability in peripheral blood mononuclear cells from systemic lupus erythematosus patients.
【2h】

Nuclear phosphotyrosyl-protein with DNA-binding ability in peripheral blood mononuclear cells from systemic lupus erythematosus patients.

机译:系统性红斑狼疮患者外周血单个核细胞中具有DNA结合能力的核磷酸酪氨酰蛋白。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This study examined the phosphorylation of cytoplasmic and nuclear proteins in peripheral blood mononuclear cells (PBMC) of systemic lupus erythematosus (SLE) patients. The cytoplasmic and nuclear protein kinase activity in PBMC from SLE patients was at least five-fold higher than that of normal healthy subjects. PBMC of SLE patients produced different nuclear endogenous substrates on phosphorylation and also displayed distinct protein kinase activity. Nuclear phosphoproteins, with human PBMC DNA-binding ability, of 38 kD and 70 kD were detected from both SLE patients and normal healthy subjects, while the 40 kD phosphoprotein, with tyrosine as the main phosphorylation residue, was found only in SLE patients. Other nuclear phosphoproteins, and most of the detected cytoplasmic phosphoproteins, were present in higher levels in both normal PBMC with mitogen stimulation, such as PHA, and SLE PBMC. The expression level of the 40 kD nuclear phosphotyrosyl-protein showed a positive correlation with the clinical disease activity of SLE. These results suggest that PBMC from SLE patients had distinct tyrosine protein kinase (TPK) activity and/or a different endogenous substrate of nuclear DNA-binding proteins in tyrosine phosphorylation. The possible significance of tyrosine phosphorylation in PBMC of SLE patients in the pathogenesis, and its clinical meaning, are discussed.
机译:这项研究检查了系统性红斑狼疮(SLE)患者外周血单核细胞(PBMC)中细胞质和核蛋白的磷酸化。 SLE患者PBMC中的胞质和核蛋白激酶活性至少比正常健康受试者高五倍。 SLE患者的PBMC在磷酸化时产生不同的核内源性底物,并且还表现出独特的蛋白激酶活性。在SLE患者和正常健康受试者中均检测到具有人PBMC DNA结合能力的核磷蛋白分别为38 kD和70 kD,而仅在SLE患者中发现了以酪氨酸为主要磷酸化残基的40 kD磷蛋白。在有丝分裂原刺激的正常PBMC中,其他核磷蛋白和大多数检测到的胞质磷蛋白均以较高水平存在,例如PHA和SLE PBMC。 40kD核磷酸酪氨酰蛋白的表达水平与SLE的临床疾病活性呈正相关。这些结果表明,来自SLE患者的PBMC在酪氨酸磷酸化中具有独特的酪氨酸蛋白激酶(TPK)活性和/或核DNA结合蛋白的不同内源性底物。讨论了SLE患者PBMC中酪氨酸磷酸化的可能意义及其临床意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号